1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

TRACON Pharmaceuticals Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2006

Location

San Diego CA US

Primary Industry

Biotechnology

About

Founded in 2006 and based in California, TRACON Pharmaceuticals Inc., formerly known as Lexington Pharmaceuticals, Inc., is a biopharmaceutical company that develops, licenses, and commercializes targeted therapies for the treatment of cancer and age-related macular degeneration.
Current Investors
Johnson & Johnson Innovation, New Enterprise Associates, 683 Capital Management

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.traconpharma.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.